Screener
ADMA Biologics ADMA Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $124.4M+2.0% | $114.49M-0.3% | $139.16M+18.4% | $134.22M+12.0% | $121.98M+13.8% | ||
| $38.12M-30.4% | $33.74M-37.2% | $50.35M-7.1% | $58.6M-2.6% | $54.76M+10.1% | ||
| $86.28M+28.3% | $80.75M+32.2% | $88.82M+40.2% | $75.63M+26.8% | $67.23M+17.0% | ||
| 69.4%+14.2pp | 70.5%+17.3pp | 63.8%+9.9pp | 56.3%+6.6pp | 55.1%+1.5pp | ||
| $6.01M+483% | $2.6M+214% | $1.38M+252% | $1.53M+271% | $1.03M+84.1% | ||
| $26.74M+20.4% | $26.74M+11.1% | $23.51M+0.8% | $21.78M+17.3% | $22.21M+33.8% | ||
| —— | —— | $775K+14.8% | $775K+14.8% | $775K+14.8% | ||
| $33.83M+38.5% | $22.48M-14.3% | $26.07M+4.2% | $24.61M+22.9% | $24.43M+33.8% | ||
| $52.45M+22.5% | $58.27M+67.1% | $62.75M+63.7% | $51.01M+28.7% | $42.8M+9.2% | ||
| 42.2%+7.1pp | 50.9%+20.5pp | 45.1%+12.5pp | 38%+4.9pp | 35.1%-1.5pp | ||
| $3.42M+86.7% | $2.1M+6.3% | $1.63M-43.5% | $1.68M-52.1% | $1.83M-51.5% | ||
| -$2.21M+18.3% | -$1.15M+19.8% | -$1.16M+68.0% | -$3.5M-21.0% | -$2.7M+19.4% | ||
| $50.24M+25.3% | $57.13M+70.8% | $61.6M+77.4% | $47.52M+29.3% | $40.1M+11.8% | ||
| $12.42M+111% | $11.8M+80.2% | $12.22M+116% | $11.09M+1,220% | $5.88M+55.1% | ||
| $37.82M+10.5% | $45.33M+68.5% | $49.38M-55.9% | $36.43M+1.4% | $34.22M+6.7% | ||
| 30.4%+2.4pp | 39.6%+16.2pp | 35.5%-59.7pp | 27.1%-2.8pp | 28.1%-1.9pp | ||
| $0.16+14.3% | $0.19+72.7% | $0.20-56.5% | $0.150.0% | $0.14+7.7% | ||
| $54.15M+20.9% | $60.07M+63.3% | $64.75M+60.6% | $53.01M+27.6% | $44.8M+9.0% | ||
| 43.5%+6.8pp | 52.5%+20.4pp | 46.5%+12.2pp | 39.5%+4.8pp | 36.7%-1.6pp | ||
| $52.45M+22.5% | $58.27M+67.1% | $62.75M+63.7% | $51.01M+28.7% | $42.8M+9.2% |
FAQ
- What is ADMA Biologics's revenue?
- ADMA Biologics (ADMA) generated $512.3M in revenue over the trailing twelve months, up 8.0% year over year.
- Is ADMA Biologics profitable?
- ADMA Biologics reported $169.0M in net income over the trailing twelve months, a 33.0% net margin.
- What are ADMA Biologics's profit margins?
- Gross margin is 64.7% and operating margin is 43.8%, with a 33.0% net margin.
- What is ADMA Biologics's earnings per share?
- ADMA Biologics's diluted EPS over the trailing twelve months is $0.70.
- Where does ADMA Biologics's income statement data come from?
- Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
